Results 161 to 170 of about 26,499 (240)

The Urokinase-Type Plasminogen Activator Receptor (uPAR) as a Mediator of Physiological and Pathological Processes: Potential Therapeutic Strategies. [PDF]

Cancers (Basel)
Iftikhar A, Mahmood N, Rabbani SA.
europepmc   +1 more source

The Plasminogen Activation System in the Central Nervous System: Implications for Epilepsy and Neuropsychiatric Disorders. [PDF]

Int J Mol Sci
Suleymanova E, Karan A.
europepmc   +1 more source

Prognostic biomarkers in oral squamous cell carcinoma: current evidence and future directions. [PDF]

Front Oncol
Brockmeyer P.
europepmc   +1 more source

Tranexamic acid impairs plasmin generation on human mesenchymal stem cells and derived membrane microvesicles, halting pericellular proteolysis. [PDF]

Front Med (Lausanne)
Abou Rjeily R, Mrad C, El-Ghazouani FZ, Toti F, Cras A, Angles-Cano E.   +5 more
europepmc   +1 more source

uPAR and cFn as candidate protein biomarkers for identifying low response to rtPA in acute ischemic stroke. [PDF]

Eur J Med Res
Wang Y, Huang Y, Li F, Han Z, Yang Z, Zhong L, Li L, Zhao H, Fan J, Zheng Y, Borlongan C, Luo Y.   +11 more
europepmc   +1 more source

Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels and Long-Term Cardiovascular Outcomes in Survivors of Breast Cancer: A UK Biobank Study. [PDF]

J Am Heart Assoc
Yadalam AK, Liu C, Sun YV, Mandawat A, Quyyumi AA, Hayek SS.   +5 more
europepmc   +1 more source

Soluble urokinase plasminogen activator receptor and interleukin-6 improves prediction of all-cause mortality and major adverse cardiovascular events in Type 1 diabetes. [PDF]

J Intern Med
Bahrami HSZ, Jørgensen PG, Hove JD, Dixen U, Rasmussen LJH, Eugen-Olsen J, Rossing P, Jensen MT.   +7 more
europepmc   +1 more source

Reversal of filarial serpin Wb123-urokinase plasminogen activator receptor mediated alternative macrophage activation by monoclonal antibody. [PDF]

PLoS Negl Trop Dis
Upadhyay P, Munjal A, Mondal A, Singh G, Mukherjee S, Siwach S, Chandoulla M, Kaushik MC, Gupta PK, Pati S, Singh S.   +10 more
europepmc   +1 more source

A Contemporary Review of Plasminogen Activator Inhibitor Type 1: Structure, Function, Genetic Architecture, and Intracellular/Extracellular Roles. [PDF]

TH Open
Wortley J, Vu J, Soogoor N, Becerra M, Sathyamoorthy M.   +4 more
europepmc   +1 more source

Molecular Docking and Simulation Analysis of Glioblastoma Cell Surface Receptors and Their Ligands: Identification of Inhibitory Drugs Targeting Fibronectin Ligand to Potentially Halt Glioblastoma Pathogenesis. [PDF]

Int J Mol Sci
Khan MWA, Alam MJ, Sherwani S, Alouffi S, Al-Motair K, Khan S, Khan SN.   +6 more
europepmc   +1 more source